Drugmaker backpedals on specialty status for COVID-19 drug

The maker of an experimental coronavirus drug is giving up the specialty status it received days ago from U.S. regulators
Source: ABC News: Health - Category: Consumer Health News Tags: Health Source Type: news

Related Links:

Biochemist leads simulations to help design new drugs, vaccines to combat coronavirus More at https://www.nsf.gov/discoveries/disc_summ.jsp?cntn_id=300313&WT.mc_id=USNSF_1 This is a Research News item.
Source: NSF Discoveries - Category: Science Source Type: research
Spain death toll passes 10,000; Italy reports 760 new deaths, taking total to 13,915, but a slower growth rate in infections; Thailand imposes national curfewLatest developments: at a glanceTop European teaching hospitals running out of coronavirus drugsSpies and export bans: the global battle for equipmentUS coronavirus – latest updatesSee all of our coronavirus coverage7.51pmBSTAfter the widespread participation in last week ’s “clap for carers” event – in which isolated people all over the UK applauded from windows, gardens and balconies in honour of National Health Service workers – ...
Source: Guardian Unlimited Science - Category: Science Authors: Tags: Coronavirus outbreak UK news World news Science Infectious diseases Middle East and North Africa South Africa Russia China Japan Asia Pacific Europe Medical research Microbiology Source Type: news
Authors: Conti P, Gallenga CE, Tetè G, Caraffa A, Ronconi G, Younes A, Toniato E, Ross R, Kritas SK Abstract SARS-CoV-2, also referred to as CoV-19, is an RNA virus which can cause severe acute respiratory diseases (COVID-19), with serious infection of the lower respiratory tract followed by bronchitis, pneumonia and fibrosis. The severity of the disease depends on the efficiency of the immune system which, if it is weak, cannot stem the infection and its symptoms. The new CoV-19 spreads in the population at a rate of 0.8-3% more than normal flu and mostly affects men, since immune genes are more expressed o...
Source: Journal of Biological Regulators and Homeostatic Agents - Category: Biomedical Science Tags: J Biol Regul Homeost Agents Source Type: research
Authors: Kim DH, Choe YJ, Jeong JY PMID: 32233163 [PubMed - in process]
Source: Journal of Korean Medical Science - Category: Biomedical Science Tags: J Korean Med Sci Source Type: research
Authors: Korean Society of Infectious Diseases and Korea Centers for Disease Control and Prevention Abstract Since the identification of the first case of coronavirus disease 2019 (COVID-19), the global number of confirmed cases as of March 15, 2020, is 156,400, with total death in 5,833 (3.7%) worldwide. Here, we summarize the morality data from February 19 when the first mortality occurred to 0 am, March 10, 2020, in Korea with comparison to other countries. The overall case fatality rate of COVID-19 in Korea was 0.7% as of 0 am, March 10, 2020. PMID: 32233161 [PubMed - in process]
Source: Journal of Korean Medical Science - Category: Biomedical Science Tags: J Korean Med Sci Source Type: research
Health secretary says he is determined to reach six-figure goal by end of AprilCoronavirus – latest updatesSee all our coronavirus coverageThe health secretary, Matt Hancock, has set the government a new target of carrying out 100,000 Covid-19 tests a day by the end of April as he sought to defend the government ’s approach.After several days of intense scrutiny over failures in testing, including the prioritisation of the public over doctors and nurses, Hancock said he was setting out a new “five-pillar” strategy.Continue reading...
Source: Guardian Unlimited Science - Category: Science Authors: Tags: Coronavirus outbreak Science Matt Hancock Health policy Politics NHS UK news Source Type: news
The coronavirus has been a far deadlier threat in New Orleans than the rest of the United States, with a per-capita death rate much higher than in New York City.Reuters Health Information
Source: Medscape Critical Care Headlines - Category: Intensive Care Tags: Diabetes & Endocrinology News Source Type: news
Commenting on the announcement by health secretary Matt Hancock today (Thursday) that the government is aiming to conduct 100,000 tests by the end of April, UNISON general secretary Dave Prentis said: “Testing is key in the fight against the virus. It’s clear the UK isn’t doing enough. We can’t waste another minute. “But the government must be realistic about what’s possible and not overpromise. Delivering over the coming weeks will be crucial to how both frontline staff and the wider public view the government’s ability to manage the crisis. “Many NHS and care staf...
Source: UNISON Health and safety news - Category: Occupational Health Authors: Tags: News Press release care workers coronavirus coronavirus testing dave prentis NHS Source Type: news
Country seen as a model for its response is told it is not doing nearly enoughCoronavirus – latest updatesSee all our coronavirus coverageGermany still needs to increase its coronavirus testing rate dramatically if it wants to successfully manage the virus, scientists are advising the government.The country has the capacity to carry out up to 500,000 tests a week, but must increase that to more than a million, or 200,000 tests a day, they say. This is despite other countries looking to Germany because of its comparatively high testing rate and relatively low death rate from Covid-19 of under 1%.Continue reading...
Source: Guardian Unlimited Science - Category: Science Authors: Tags: Coronavirus outbreak Germany Health Science Society Europe Source Type: news
Blood centers are ramping up efforts to collect plasma from people who recovered from COVID-19 in hopes their coronavirus antibodies could save lives.
Source: Los Angeles Times - Science - Category: Science Authors: Source Type: news
More News: Coronavirus | COVID-19 | Health | Wuhan Coronavirus